Removing hemp from the federal narcotics Schedule 1 list does not mean that all CBD products are now permitted, the US Food and Drug Administration (FDA) has warned ...
The presence of CBD could render cannabis useless as a treatment for glaucoma, new research warns. Long-term use of the substance may even worsen one of the main risk factors for the eye disease ...
New York state has set out a series of new regulatory requirements for businesses wanting to produce or sell CBD products in its jurisdiction, with strict manufacturing, reporting and product category guidelines ...
The US Congress has approved a compromise version of the 2018 Farm Bill which will remove industrial hemp from the federal narcotics Schedule 1 list, potentially giving a green light to development of the CBD...
A Canadian company is facing the prospect of losing its licence to produce and sell cannabis products. It would mark the first time Health Canada has revoked a licence since the country began regulating medical...
Turning Point Brands, one of America’s largest smokeless tobacco and vapour companies, has taken a minority stake in Canadian American Standard Hemp, a company dedicated to CBD products ...
US tobacco giant Altria has bought a 45% stake in Canadian cannabis company the Cronos Group, with the option to take a majority 55% stake within the next four years ...
The merger of two companies in the US CBD sector – Level Brands and Cure Based Developments – is dependent on the US Farm Bill legalising CBD at federal level ...
Charlotte’s Web Holdings, which claims to be the market leader in “innovative hemp-based, CBD wellness products”, says it expects to add national drugstores to its thousands of locations in the US soon ...
Canadian medical cannabis company Wayland Group has agreed to purchase 51% of the British firm Theros Pharma for £27.8m – if it succeeds in gaining a UK cultivation or import licence ...
Securing cannabis supplies for research purposes is the focus of an information request from the US federal government. They are asking businesses about the ability to analyse, produce, and even distribute cannabis products for research....
With the ousting of attorney general Jeff Sessions from the Trump administration, members of the US cannabis industry have perked up, hoping the anti-cannabis agenda will exit with him ...
Investment in Europe continues as companies in the medical cannabis sector anticipate further loosening of regulations. In the pure-CBD sector, two American firms are eyeing expansion ...
The number of cannabidiol-based pharmaceutical products in the pipeline continues to grow, with the US Food and Drug Administration (FDA) recently granting yet another orphan drug designation for CBD ...
American CBD company CV Sciences announces sales of $13.6m in the third quarter of 2018 and $34m over the first nine months of the year while Terra Tech reveals merger ...
Two North American companies have announced collaborations with established drug delivery firms to produce and expand distribution for oral CBD strips – soluble strips that dissolve in the mouth ...
Voters in Michigan have voted to legalise the recreational use of cannabis, while those in North Dakota rejected it. In Utah and Missouri medical cannabis use was approved on the day the US turned out...
Colorado-based Mile High Labs has announced $35m in Series A funding from institutional and private equity investors to expand its CBD production capacity ...
Many cannabis strains marketed as distinct are in fact chemically much the same, but there may also be non-obvious differences and their effects on humans should not be judged purely on THC and CBD content,...
Comments invited by the FDA on the potential abuse and medical usefulness of CBD and other cannabis-derived substances will be submitted to the World Health Organization (WHO) ...
A major CBD show is to be held in Las Vegas next month in what is billed as “an epic collaboration of two industries”. The CBD.io event will take place on 9th and 10th November...
A deadline for the federal legislature to pass a bill expected to remove hemp and low-THC cannabis from the federal list of narcotics lapsed on 30th September, leaving US hemp farmers in regulatory uncertainty...
Canadian company Emerald Health Therapeutics is set to sign a deal to use an extraction facility capable of processing 1000 tonnes of biomass to produce 600m softgel CBD capsules a year ...
Intrexon, an American biotech company listed on the Nasdaq stock exchange, has announced a development in its microbial platform capable of producing cannabinoids for medical use ...
A Canadian company has come under regulatory scrutiny and lost a major business deal after it attempted to recruit new medical cannabis users at a dance club party using scantily clad women in nurses’ uniforms...
Tobacco giant Imperial Brands is looking to new markets such as cannabis and CBD in the near future. “At the moment we are looking to understand this space”, said Alison Cooper, CEO of Imperial Brands, about the...
Cannabis growers in Massachusetts have indicated they may sue the state’s Cannabis Control Commission over a dispute that appears to have delayed the start of legal sales there ...
Rare cannabinoids that cannot practically be extracted from hemp will instead be manufactured by specially-created micro-organisms in a partnership between a Canadian and a US company ...
Cannabis and nicotine together have notably different effects on the brain than either of them taken on their own. That’s the conclusion of US researchers who noted that cannabis is commonly consumed in conjunction with...
Although all three states have laws permitting CBD sales, retailers in Ohio, Iowa and Alabama have been told they are breaking the law and ordered to stop ...
A Polish CBD company has been acquired by a publicly traded Canadian medicinal cannabis company in a cash-and-shares deal worth more than $15m USD plus future incentives ...
Crossover between vapourisers and e-cigarettes has been found to be quite low and companies dedicated to both vapourisers and e-cigarettes are rare ...
Vaping businesses in the US are experiencing a shift in consumer preferences for methods of extracting CBD and THC from cannabis, with more manufacturers developing distillers to help meet the growing demand for purer products...
Hybrid THC-CBD cannabis products – also called high CBD cannabis products – are on the rise in those US states where both medical and recreational forms of cannabis are legal ...
Synthetic cannabinoid products being sold in convenience stores and gas stations across the US are contaminated with an ingredient commonly found in rat poison, the US FDA says ...
US government agencies have questioned the legality of cannabidiol (CBD) – just as the industry is starting to benefit from increased public awareness ...
The first ever FDA-approved cannabis-derived product came a step nearer reality when an independent panel at the agency recommended it as a “safe” and “efficacious” treatment for childhood seizures ...
In our latest report on developments in the legal cannabis market, CBD-Intel considers whether PMI may be setting up a future move in that direction. We also look at the potential dangers of synthetic cannabis...
Isodiol International, a Canadian-based pharmaceutical producer, is to enter the vaping industry through the acquisition of US e-liquid firm Bradley’s Bioscience ...
Enovap, an innovative French hardware manufacturer, has announced plans to move into the US market, where it hopes to apply its technology to medicinal cannabis use ...
E-cigarette firms who already have devices on the market are manoeuvring to see how their products can serve the growing marijuana industry – and they face competition there from some well-financed...
39 U.S. states and the District of Columbia have laws that legalise and/or decriminalise marijuana use or possession to various extents. E-cig companies are well positioned to enter the emerging marijuana market because of their...
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.